Early initiation of anti-relapse antiarrhythmic therapy in patients with atrial fibrillation and flutter after pharmacological cardioversion with refralon.

Gagloeva, D A; Dzaurova, Kh M; Zelberg, M A; Mironov, N Yu; Yuricheva, Yu A; Sokolov, S F; Golitsyn, S P

Gagloeva, D A; Dzaurova, Kh M; Zelberg, M A; Mironov, N Yu; Yuricheva, Yu A; Sokolov, S F; Golitsyn, S P.

Affiliation

Gagloeva DA; Chazov National Medical Research Center of Cardiology, Moscow.
Dzaurova KM; Chazov National Medical Research Center of Cardiology, Moscow.
Zelberg MA; Chazov National Medical Research Center of Cardiology, Moscow.
Mironov NY; Chazov National Medical Research Center of Cardiology, Moscow.
Yuricheva YA; Chazov National Medical Research Center of Cardiology, Moscow.
Sokolov SF; Chazov National Medical Research Center of Cardiology, Moscow.
Golitsyn SP; Chazov National Medical Research Center of Cardiology, Moscow.

Kardiologiia ; 63(6): 21-27, 2023 Jun 30.

Article in Ru, En | MEDLINE | ID: mdl-37470730

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Atrial Flutter / Long QT Syndrome Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans / Male Language: En / Ru Journal: Kardiologiia Year: 2023 Document type: Article Country of publication: Rusia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google